Eastwood Bio-Medical Canada Inc. (EWOOF)
USD 0.69
(-42.19%)
USD 0.69
(-42.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 625.36 Thousand | 953.76 Thousand | 791.8 Thousand | 538.74 Thousand | 983.67 Thousand | 743.97 Thousand |
| Cost of Revenue | 319.57 Thousand | 369.73 Thousand | 506.84 Thousand | 458.07 Thousand | 588.73 Thousand | 361.29 Thousand |
| Gross Profit | 305.79 Thousand | 584.02 Thousand | 284.96 Thousand | 80.67 Thousand | 394.93 Thousand | 382.67 Thousand |
| Operating Expenses | 548.36 Thousand | 686.58 Thousand | 785.53 Thousand | 818.59 Thousand | 834.11 Thousand | 948.6 Thousand |
| Selling, General and Administrative Expenses | 670.03 Thousand | 686.58 Thousand | 785.53 Thousand | 818.59 Thousand | 834.11 Thousand | 650.32 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 585.00 | - | 412.00 | 2255.00 | 1991.00 |
| Cost and Expenses | 867.93 Thousand | 1.05 Million | 1.29 Million | 1.27 Million | 1.42 Million | 1.3 Million |
| Operating Income | -364.61 Thousand | -102.55 Thousand | -500.57 Thousand | -737.92 Thousand | -439.17 Thousand | -190.76 Thousand |
| Interest Expense | 28.16 Thousand | 7855.33 | 2250.19 | 1780.48 | 4046.87 | 1309.00 |
| Income Tax Expense | - | -5.14 | 1.61 | -1032.74 | -12.48 Thousand | 298.03 Thousand |
| Earnings before Tax | -546.59 Thousand | -109.98 Thousand | -487.15 Thousand | -639.31 Thousand | -439.24 Thousand | -861.97 Thousand |
| Net Income | -546.59 Thousand | -109.98 Thousand | -487.15 Thousand | -639.31 Thousand | -439.24 Thousand | -861.97 Thousand |
| Earnings Per Share Basic | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million |
| Gross Margin | 0.49 | 0.61 | 0.36 | 0.15 | 0.40 | 0.51 |
| EBIT Margin | -0.66 | -0.03 | -0.52 | -1.22 | -0.41 | -0.22 |
| Profit Margin | -0.87 | -0.12 | -0.62 | -1.19 | -0.45 | -1.16 |
| EBITDA | -410.58 Thousand | -32.32 Thousand | -524.11 Thousand | -746.09 Thousand | -531.23 Thousand | -522.19 Thousand |
| Earnings Before Tax Margin | -0.58 | -0.11 | -0.63 | -1.37 | -0.45 | -0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 188.26 Thousand | 135.19 Thousand | 201 Thousand | 625.36 Thousand | 93 Thousand | 141.74 Thousand |
| Cost of Revenue | 57.33 Thousand | 48.75 Thousand | 60.78 Thousand | 307.96 Thousand | 76.79 Thousand | 67 Thousand |
| Gross Profit | 130.92 Thousand | 86.44 Thousand | 140.21 Thousand | 317.39 Thousand | 16.21 Thousand | 74.73 Thousand |
| Operating Expenses | 232.18 Thousand | 220.35 Thousand | 204.31 Thousand | 682 Thousand | 125.69 Thousand | 161.97 Thousand |
| Selling, General and Administrative Expenses | 148.71 Thousand | 116.25 Thousand | 139.79 Thousand | - | 125.69 Thousand | 161.97 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 83.47 Thousand | - | - | - | - | - |
| Cost and Expenses | 289.52 Thousand | 269.1 Thousand | 265.09 Thousand | 989.97 Thousand | 202.48 Thousand | 228.98 Thousand |
| Operating Income | -90.55 Thousand | -139.93 Thousand | -73.17 Thousand | -364.61 Thousand | -109.47 Thousand | -87.24 Thousand |
| Interest Expense | - | - | - | 20.29 Thousand | 14.57 Thousand | 1628.73 |
| Income Tax Expense | 14.31 Thousand | -3769.00 | -9862.00 | -90.18 Thousand | -1.00 | -0.76 |
| Earnings before Tax | -115.57 Thousand | -130.13 Thousand | -54.23 Thousand | -393.83 Thousand | -132.74 Thousand | -88.9 Thousand |
| Net Income | -115.57 Thousand | -130.13 Thousand | -54.23 Thousand | -393.83 Thousand | -132.74 Thousand | -88.9 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million | 68.88 Million |
| Gross Margin | 0.70 | 0.64 | 0.70 | 0.51 | 0.17 | 0.53 |
| EBIT Margin | -0.34 | -0.84 | -0.23 | - | -0.97 | -0.47 |
| Profit Margin | -0.61 | -0.96 | -0.27 | -0.63 | -1.43 | -0.63 |
| EBITDA | -63.91 Thousand | -113.3 Thousand | -46.54 Thousand | - | -90.05 Thousand | -66.8 Thousand |
| Earnings Before Tax Margin | -0.48 | -1.04 | -0.36 | -0.58 | -1.18 | -0.62 |
000430
PHGE-UN
AFP
8TRA
FRE
015360